Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Erskine

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Drug and Therapeutics Bulletin|March 29, 2019
DOAC dosing in renal impairmentDavid Erskine
Drug and Therapeutics Bulletin|February 2, 2022
Is the path to greener inhalers paved with good intentions?David Erskine
Drug and Therapeutics Bulletin|February 28, 2020
Dapagliflozin for type 1 diabetes: ensuring benefits outweigh the risksDavid Erskine
Drug and Therapeutics Bulletin|February 6, 2021
Opioid safety: striking the right balanceDavid Erskine, Steven Wanklyn
Drug and Therapeutics Bulletin|February 25, 2021
What is the significance of nitrosamine contamination in medicines?David Erskine, David Wood
Drug and Therapeutics Bulletin|June 28, 2023
Whither evidence?David Erskine, John Minshull
Clinical Interventions in Aging|October 4, 2014
Predicting adverse drug reactions in older adults; a systematic review of the risk prediction modelsJennifer M Stevenson, Josceline L Williams, Thomas G Burnham, et al.
Physical Review. E|December 17, 2020
Benchmarking boron carbide equation of state using computation and experimentShuai Zhang, Michelle C Marshall, Lin H Yang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Drug and Therapeutics Bulletin|March 29, 2019
DOAC dosing in renal impairmentDavid Erskine
Drug and Therapeutics Bulletin|February 2, 2022
Is the path to greener inhalers paved with good intentions?David Erskine
Drug and Therapeutics Bulletin|February 28, 2020
Dapagliflozin for type 1 diabetes: ensuring benefits outweigh the risksDavid Erskine
Drug and Therapeutics Bulletin|February 6, 2021
Opioid safety: striking the right balanceDavid Erskine, Steven Wanklyn
Drug and Therapeutics Bulletin|February 25, 2021
What is the significance of nitrosamine contamination in medicines?David Erskine, David Wood
Drug and Therapeutics Bulletin|June 28, 2023
Whither evidence?David Erskine, John Minshull
Clinical Interventions in Aging|October 4, 2014
Predicting adverse drug reactions in older adults; a systematic review of the risk prediction modelsJennifer M Stevenson, Josceline L Williams, Thomas G Burnham, et al.
Physical Review. E|December 17, 2020
Benchmarking boron carbide equation of state using computation and experimentShuai Zhang, Michelle C Marshall, Lin H Yang, et al.
Pageof 1